View Future GrowthNeoCore Technology 과거 순이익 실적과거 기준 점검 0/6NeoCore Technology 의 수입은 연평균 -11.5%의 비율로 감소해 온 반면, Biotechs 산업은 연평균 21.8%의 비율로 증가했습니다. 매출은 연평균 18.8%의 비율로 증가해 왔습니다.핵심 정보-11.50%순이익 성장률4.48%주당순이익(EPS) 성장률Biotechs 산업 성장률12.22%매출 성장률18.84%자기자본이익률-7.81%순이익률-8.67%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.모든 업데이트 보기Recent updatesReported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.공시 • Mar 05NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026. Location: no,9, lu k`o 1st rd., lujhu district, kaohsiung city TaiwanReported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.New Risk • Mar 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 34% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.56b market cap, or US$47.5m).공시 • Mar 07NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025. Location: no,31, k`o chung, jhunan township, miaoli county TaiwanNew Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.30b market cap, or US$40.1m).Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.36 loss per share (vs NT$0.50 loss in 3Q 2023)Third quarter 2024 results: NT$0.36 loss per share (improved from NT$0.50 loss in 3Q 2023). Revenue: NT$16.5m (up 18% from 3Q 2023). Net loss: NT$14.0m (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.Reported Earnings • Aug 17Second quarter 2024 earnings released: NT$0.39 loss per share (vs NT$0.39 loss in 2Q 2023)Second quarter 2024 results: NT$0.39 loss per share (in line with 2Q 2023). Revenue: NT$17.7m (up 40% from 2Q 2023). Net loss: NT$15.1m (flat on 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Revenue is less than US$5m (NT$61m revenue, or US$1.9m). Market cap is less than US$100m (NT$1.33b market cap, or US$40.8m).Reported Earnings • May 20First quarter 2024 earnings released: NT$0.40 loss per share (vs NT$0.45 loss in 1Q 2023)First quarter 2024 results: NT$0.40 loss per share. Revenue: NT$15.8m (down 20% from 1Q 2023). Net loss: NT$15.6m (loss widened 63% from 1Q 2023).공시 • Apr 11NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024.Reported Earnings • Mar 20Full year 2023 earnings released: NT$1.87 loss per share (vs NT$1.49 loss in FY 2022)Full year 2023 results: NT$1.87 loss per share (further deteriorated from NT$1.49 loss in FY 2022). Revenue: NT$64.7m (down 27% from FY 2022). Net loss: NT$64.6m (loss widened 129% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.New Risk • Dec 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (105% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Revenue is less than US$5m (NT$74m revenue, or US$2.3m). Market cap is less than US$100m (NT$895.1m market cap, or US$28.4m).Reported Earnings • Aug 11Second quarter 2023 earnings released: NT$0.39 loss per share (vs NT$0.52 loss in 2Q 2022)Second quarter 2023 results: NT$0.39 loss per share. Revenue: NT$12.7m (up 10.0% from 2Q 2022). Net loss: NT$15.2m (loss widened 53% from 2Q 2022).Reported Earnings • Mar 31Full year 2022 earnings released: NT$1.49 loss per share (vs NT$0.91 loss in FY 2021)Full year 2022 results: NT$1.49 loss per share (further deteriorated from NT$0.91 loss in FY 2021). Revenue: NT$89.0m (flat on FY 2021). Net loss: NT$28.2m (loss widened 64% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.Reported Earnings • Nov 19Third quarter 2022 earnings released: NT$0.44 loss per share (vs NT$0.23 loss in 3Q 2021)Third quarter 2022 results: NT$0.44 loss per share (further deteriorated from NT$0.23 loss in 3Q 2021). Revenue: NT$21.1m (up 14% from 3Q 2021). Net loss: NT$8.28m (loss widened 86% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Reported Earnings • Aug 18Second quarter 2022 earnings released: NT$0.52 loss per share (vs NT$0.19 loss in 2Q 2021)Second quarter 2022 results: NT$0.52 loss per share (down from NT$0.19 loss in 2Q 2021). Revenue: NT$11.5m (down 40% from 2Q 2021). Net loss: NT$9.94m (loss widened 171% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • May 11First quarter 2022 earnings released: NT$0.21 loss per share (vs NT$0.13 loss in 1Q 2021)First quarter 2022 results: NT$0.21 loss per share (down from NT$0.13 loss in 1Q 2021). Revenue: NT$28.8m (up 15% from 1Q 2021). Net loss: NT$3.94m (loss widened 56% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.09 loss per share (vs NT$0.097 loss in 3Q 2020)The company reported a soft third quarter result with weaker revenues and control over costs, although losses reduced. Third quarter 2021 results: Revenue: NT$18.4m (down 29% from 3Q 2020). Net loss: NT$4.44m (loss narrowed 5.6% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 09Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.12 loss in 2Q 2020)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2021 results: Revenue: NT$19.3m (down 15% from 2Q 2020). Net loss: NT$3.66m (loss narrowed 36% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • May 16First quarter 2021 earnings released: NT$0.05 loss per share (vs NT$0.20 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: NT$25.0m (up 18% from 1Q 2020). Net loss: NT$2.53m (loss narrowed 74% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.분석 기사 • Apr 19DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Mar 19Full year 2020 earnings released: NT$0.56 loss per share (vs NT$0.25 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$93.3m (down 11% from FY 2019). Net loss: NT$27.1m (loss widened 128% from FY 2019). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.공시 • Mar 09DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021.Is New 90 Day High Low • Mar 05New 90-day high: NT$7.65The company is up 4.0% from its price of NT$7.34 on 04 December 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 25New 90-day low: NT$5.15The company is down 34% from its price of NT$7.80 on 28 October 2020. The Taiwanese market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 1.0% over the same period.Is New 90 Day High Low • Jan 06New 90-day low: NT$6.13The company is down 35% from its price of NT$9.45 on 08 October 2020. The Taiwanese market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 3.0% over the same period.분석 기사 • Jan 04DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Dec 08New 90-day low: NT$7.00The company is down 35% from its price of NT$10.75 on 09 September 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.Is New 90 Day High Low • Nov 17New 90-day low: NT$7.27The company is down 29% from its price of NT$10.20 on 19 August 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.Reported Earnings • Nov 10Third quarter 2020 earnings released: NT$0.09 loss per shareThe company reported a poor third quarter result with weaker earnings and control over expenses, although revenues were flat. Third quarter 2020 results: Revenue: NT$25.9m (flat on 3Q 2019). Net loss: NT$4.70m (down 280% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Oct 28New 90-day low: NT$7.80The company is down 22% from its price of NT$10.00 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 7.0% over the same period.Is New 90 Day High Low • Sep 30New 90-day low: NT$7.87The company is down 16% from its price of NT$9.41 on 02 July 2020. The Taiwanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 9.0% over the same period.매출 및 비용 세부 내역NeoCore Technology가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TPEX:4131 매출, 비용 및 순이익 (TWD Millions)날짜매출순이익일반관리비연구개발비31 Mar 26236-201311531 Dec 25245-311321730 Sep 25190-201121830 Jun 25151-18951731 Mar 25115-45751631 Dec 2462-48611630 Sep 2468-65601730 Jun 2466-71572331 Mar 2461-71562531 Dec 2365-65512530 Sep 2374-50482130 Jun 2381-39461331 Mar 2380-3444931 Dec 2289-2845730 Sep 2288-2944630 Jun 2285-2544631 Mar 2293-1943631 Dec 2189-1742630 Sep 2186-1843630 Jun 2194-1844531 Mar 2197-2046531 Dec 2093-2747630 Sep 2096-2849630 Jun 2097-2049631 Mar 2097-1850731 Dec 19104-1254730 Sep 1999-1244830 Jun 19100-2146931 Mar 1987-2443831 Dec 1862-2533830 Sep 1842-2233830 Jun 1818-2224831 Mar 1812-2219731 Dec 1712-2120730 Sep 1714-25201030 Jun 1716-27201031 Mar 1716-28201031 Dec 1617-28211130 Sep 1618-20211030 Jun 1619-17201031 Mar 1620-18211131 Dec 1522-17211130 Sep 1526-19241230 Jun 1526-222514양질의 수익: 4131 은(는) 현재 수익성이 없습니다.이익 마진 증가: 4131는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 4131은 수익성이 없으며 지난 5년 동안 손실이 연평균 11.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 4131의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 4131은 수익성이 없어 지난 해 수익 성장률을 Biotechs 업계(12.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 4131는 현재 수익성이 없으므로 자본 수익률이 음수(-7.81%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/29 15:00종가2026/06/26 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스NeoCore Technology Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.
Reported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
공시 • Mar 05NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026. Location: no,9, lu k`o 1st rd., lujhu district, kaohsiung city Taiwan
Reported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.
New Risk • Mar 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 34% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.56b market cap, or US$47.5m).
공시 • Mar 07NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025. Location: no,31, k`o chung, jhunan township, miaoli county Taiwan
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.30b market cap, or US$40.1m).
Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.36 loss per share (vs NT$0.50 loss in 3Q 2023)Third quarter 2024 results: NT$0.36 loss per share (improved from NT$0.50 loss in 3Q 2023). Revenue: NT$16.5m (up 18% from 3Q 2023). Net loss: NT$14.0m (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 17Second quarter 2024 earnings released: NT$0.39 loss per share (vs NT$0.39 loss in 2Q 2023)Second quarter 2024 results: NT$0.39 loss per share (in line with 2Q 2023). Revenue: NT$17.7m (up 40% from 2Q 2023). Net loss: NT$15.1m (flat on 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Revenue is less than US$5m (NT$61m revenue, or US$1.9m). Market cap is less than US$100m (NT$1.33b market cap, or US$40.8m).
Reported Earnings • May 20First quarter 2024 earnings released: NT$0.40 loss per share (vs NT$0.45 loss in 1Q 2023)First quarter 2024 results: NT$0.40 loss per share. Revenue: NT$15.8m (down 20% from 1Q 2023). Net loss: NT$15.6m (loss widened 63% from 1Q 2023).
공시 • Apr 11NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024.
Reported Earnings • Mar 20Full year 2023 earnings released: NT$1.87 loss per share (vs NT$1.49 loss in FY 2022)Full year 2023 results: NT$1.87 loss per share (further deteriorated from NT$1.49 loss in FY 2022). Revenue: NT$64.7m (down 27% from FY 2022). Net loss: NT$64.6m (loss widened 129% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.
New Risk • Dec 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (105% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Revenue is less than US$5m (NT$74m revenue, or US$2.3m). Market cap is less than US$100m (NT$895.1m market cap, or US$28.4m).
Reported Earnings • Aug 11Second quarter 2023 earnings released: NT$0.39 loss per share (vs NT$0.52 loss in 2Q 2022)Second quarter 2023 results: NT$0.39 loss per share. Revenue: NT$12.7m (up 10.0% from 2Q 2022). Net loss: NT$15.2m (loss widened 53% from 2Q 2022).
Reported Earnings • Mar 31Full year 2022 earnings released: NT$1.49 loss per share (vs NT$0.91 loss in FY 2021)Full year 2022 results: NT$1.49 loss per share (further deteriorated from NT$0.91 loss in FY 2021). Revenue: NT$89.0m (flat on FY 2021). Net loss: NT$28.2m (loss widened 64% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 19Third quarter 2022 earnings released: NT$0.44 loss per share (vs NT$0.23 loss in 3Q 2021)Third quarter 2022 results: NT$0.44 loss per share (further deteriorated from NT$0.23 loss in 3Q 2021). Revenue: NT$21.1m (up 14% from 3Q 2021). Net loss: NT$8.28m (loss widened 86% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 18Second quarter 2022 earnings released: NT$0.52 loss per share (vs NT$0.19 loss in 2Q 2021)Second quarter 2022 results: NT$0.52 loss per share (down from NT$0.19 loss in 2Q 2021). Revenue: NT$11.5m (down 40% from 2Q 2021). Net loss: NT$9.94m (loss widened 171% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • May 11First quarter 2022 earnings released: NT$0.21 loss per share (vs NT$0.13 loss in 1Q 2021)First quarter 2022 results: NT$0.21 loss per share (down from NT$0.13 loss in 1Q 2021). Revenue: NT$28.8m (up 15% from 1Q 2021). Net loss: NT$3.94m (loss widened 56% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.09 loss per share (vs NT$0.097 loss in 3Q 2020)The company reported a soft third quarter result with weaker revenues and control over costs, although losses reduced. Third quarter 2021 results: Revenue: NT$18.4m (down 29% from 3Q 2020). Net loss: NT$4.44m (loss narrowed 5.6% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 09Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.12 loss in 2Q 2020)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2021 results: Revenue: NT$19.3m (down 15% from 2Q 2020). Net loss: NT$3.66m (loss narrowed 36% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16First quarter 2021 earnings released: NT$0.05 loss per share (vs NT$0.20 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: NT$25.0m (up 18% from 1Q 2020). Net loss: NT$2.53m (loss narrowed 74% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
분석 기사 • Apr 19DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Mar 19Full year 2020 earnings released: NT$0.56 loss per share (vs NT$0.25 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$93.3m (down 11% from FY 2019). Net loss: NT$27.1m (loss widened 128% from FY 2019). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
공시 • Mar 09DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021.
Is New 90 Day High Low • Mar 05New 90-day high: NT$7.65The company is up 4.0% from its price of NT$7.34 on 04 December 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 25New 90-day low: NT$5.15The company is down 34% from its price of NT$7.80 on 28 October 2020. The Taiwanese market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Jan 06New 90-day low: NT$6.13The company is down 35% from its price of NT$9.45 on 08 October 2020. The Taiwanese market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 3.0% over the same period.
분석 기사 • Jan 04DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Dec 08New 90-day low: NT$7.00The company is down 35% from its price of NT$10.75 on 09 September 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Nov 17New 90-day low: NT$7.27The company is down 29% from its price of NT$10.20 on 19 August 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.
Reported Earnings • Nov 10Third quarter 2020 earnings released: NT$0.09 loss per shareThe company reported a poor third quarter result with weaker earnings and control over expenses, although revenues were flat. Third quarter 2020 results: Revenue: NT$25.9m (flat on 3Q 2019). Net loss: NT$4.70m (down 280% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Oct 28New 90-day low: NT$7.80The company is down 22% from its price of NT$10.00 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 7.0% over the same period.
Is New 90 Day High Low • Sep 30New 90-day low: NT$7.87The company is down 16% from its price of NT$9.41 on 02 July 2020. The Taiwanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 9.0% over the same period.